Clinical analysis of 60 cases with maxillary squamous cell carcinoma
10.3760/cma.j.issn.1673-0860.2010.07.009
- VernacularTitle:上颌窦鳞状细胞癌60例临床分析
- Author:
Zai-Xing ZHANG
1
;
Zheng-Jiang LI
;
Zhen-Gang XU
;
Ping-Zhang TANG
;
Zong-Min ZHANG
;
Chang-Ming AN
Author Information
1. 中国医学科学院北京协和医学院肿瘤医院
- Keywords:
Carcinoma,squamous cell;
Maxillary sinus neoplasms;
Combined modality therapy;
Prognosis
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2010;45(7):560-564
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical characters, treatment modalities and prognosis of patients with maxillary squamous cell carcinoma. Methods The clinical data of 60 patients with maxillary squamous cell carcinoma treatment between January 1994 and December 2004 were analyzed retrospectively.The patients were treated with three therapy modalities including radiotherapy alone(22 cases) ,radiotheraphy and surgery( R +S, 29 cases)and concurrent chemo-radio-therapy adjuvant surgery (CCR + S, 9 cases).Results The five year survival rate were 18.2%, 51.7% and 33.3% for patients in the radiotherapy alone group, the R + S group and the CCR + S group, respectively. Patients receiving R + S combined modality therapy had a significantly higher five year survival rate than the patients who were treated radiotherapy alone ( λ2 = 15.62, P <0.01 ). The five year survival rate(51.7% ) of patients in R + S group was significantly higher than that (33. 3% ) of patients in CCR + S group ( λ2 = 4. 28, P < 0.05 ), and also higher than that ( 18. 2% ) of patients in radiotherapy group( λ2 =9.49 ,P <0. 01 ). Conclusions The combined therapy of radiation and surgery was a good choice of treatment for the patients with maxillary sinus squamous cell carcinoma. The role of concurrent chemo-radiotherapy adjuvant surgery in the treatment of maxillary sinus squamous cell carcinoma needs further to research.
